![](/img/cover-not-exists.png)
PND68 COST-EFFECTIVENESS OF OCRELIZUMAB COMPARED TO FINGOLIMOD OR DMF IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CZECH REPUBLIC
Dolezel, J., Havrdova, E.K., Skalicky, D., Pour, M.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.1341
Date:
May, 2019
File:
PDF, 382 KB
english, 2019